Cancer Research UK logo.
SearchDonate
  • Search

A study to find out how long people with melanoma should have treatment with pembrolizumab and nivolumab (DANTE)

Overview

Cancer types:

Melanoma, Secondary cancers

Status:

Closed

Phase:

Phase 3

Details

This study is for people with melanoma that has spread to other parts of the body (metastatic).

Recruitment start: 1 September 2018

Recruitment end: 15 September 2023

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Sarah Danson

Supported by

Sheffield Teaching Hospitals NHS Foundation Trust

The University of Sheffield

Leeds Institute of Clinical Trials Research

University of Leeds

Last reviewed: 25 October 2023

CRUK internal database number: 15706

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.